Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis

Tomonori Kaneda, Yoshiko Sonoda, Kumi Ando, Takaharu Suzuki, Yasuhiro Sasaki, Tomoyuki Oshio, Megumi Tago, Tadashi Kasahara

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

This study focused on the role of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase important for many cellular processes, in the proliferation, adhesion, and invasion of melanoma cells in vitro and in vivo. We found that the Y925F-mutation of FAK in B16F10 melanoma cells suppressed metastasis in an experimental model, which correlated well with decreased extracellular matrix dependent proliferative capability, adhesive, migrational, and invasive capabilities. Transduction of the mutation Y925F resulted in a down-regulation of the phosphorylation of Erk, the expression of VEGF, and the association of FAK with paxillin. The results provide clear evidence that 925Y of FAK is critical for melanoma metastasis and this phosphorylation site will be an anti-metastatic target.

Original languageEnglish
Pages (from-to)354-361
Number of pages8
JournalCancer Letters
Volume270
Issue number2
DOIs
Publication statusPublished - 2008 Nov 8

Fingerprint

Focal Adhesion Protein-Tyrosine Kinases
Melanoma
Cell Proliferation
Neoplasm Metastasis
Mutation
Phosphorylation
Paxillin
Adhesives
Protein-Tyrosine Kinases
Vascular Endothelial Growth Factor A
Extracellular Matrix
Theoretical Models
Down-Regulation

Keywords

  • B16F10 cells
  • Erk
  • FAK
  • Metastasis
  • Paxillin
  • Y925F-mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kaneda, T., Sonoda, Y., Ando, K., Suzuki, T., Sasaki, Y., Oshio, T., ... Kasahara, T. (2008). Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. Cancer Letters, 270(2), 354-361. https://doi.org/10.1016/j.canlet.2008.05.042

Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. / Kaneda, Tomonori; Sonoda, Yoshiko; Ando, Kumi; Suzuki, Takaharu; Sasaki, Yasuhiro; Oshio, Tomoyuki; Tago, Megumi; Kasahara, Tadashi.

In: Cancer Letters, Vol. 270, No. 2, 08.11.2008, p. 354-361.

Research output: Contribution to journalArticle

Kaneda, T, Sonoda, Y, Ando, K, Suzuki, T, Sasaki, Y, Oshio, T, Tago, M & Kasahara, T 2008, 'Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis', Cancer Letters, vol. 270, no. 2, pp. 354-361. https://doi.org/10.1016/j.canlet.2008.05.042
Kaneda, Tomonori ; Sonoda, Yoshiko ; Ando, Kumi ; Suzuki, Takaharu ; Sasaki, Yasuhiro ; Oshio, Tomoyuki ; Tago, Megumi ; Kasahara, Tadashi. / Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. In: Cancer Letters. 2008 ; Vol. 270, No. 2. pp. 354-361.
@article{f62053703cd444dca999111d2f5909c8,
title = "Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis",
abstract = "This study focused on the role of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase important for many cellular processes, in the proliferation, adhesion, and invasion of melanoma cells in vitro and in vivo. We found that the Y925F-mutation of FAK in B16F10 melanoma cells suppressed metastasis in an experimental model, which correlated well with decreased extracellular matrix dependent proliferative capability, adhesive, migrational, and invasive capabilities. Transduction of the mutation Y925F resulted in a down-regulation of the phosphorylation of Erk, the expression of VEGF, and the association of FAK with paxillin. The results provide clear evidence that 925Y of FAK is critical for melanoma metastasis and this phosphorylation site will be an anti-metastatic target.",
keywords = "B16F10 cells, Erk, FAK, Metastasis, Paxillin, Y925F-mutation",
author = "Tomonori Kaneda and Yoshiko Sonoda and Kumi Ando and Takaharu Suzuki and Yasuhiro Sasaki and Tomoyuki Oshio and Megumi Tago and Tadashi Kasahara",
year = "2008",
month = "11",
day = "8",
doi = "10.1016/j.canlet.2008.05.042",
language = "English",
volume = "270",
pages = "354--361",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis

AU - Kaneda, Tomonori

AU - Sonoda, Yoshiko

AU - Ando, Kumi

AU - Suzuki, Takaharu

AU - Sasaki, Yasuhiro

AU - Oshio, Tomoyuki

AU - Tago, Megumi

AU - Kasahara, Tadashi

PY - 2008/11/8

Y1 - 2008/11/8

N2 - This study focused on the role of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase important for many cellular processes, in the proliferation, adhesion, and invasion of melanoma cells in vitro and in vivo. We found that the Y925F-mutation of FAK in B16F10 melanoma cells suppressed metastasis in an experimental model, which correlated well with decreased extracellular matrix dependent proliferative capability, adhesive, migrational, and invasive capabilities. Transduction of the mutation Y925F resulted in a down-regulation of the phosphorylation of Erk, the expression of VEGF, and the association of FAK with paxillin. The results provide clear evidence that 925Y of FAK is critical for melanoma metastasis and this phosphorylation site will be an anti-metastatic target.

AB - This study focused on the role of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase important for many cellular processes, in the proliferation, adhesion, and invasion of melanoma cells in vitro and in vivo. We found that the Y925F-mutation of FAK in B16F10 melanoma cells suppressed metastasis in an experimental model, which correlated well with decreased extracellular matrix dependent proliferative capability, adhesive, migrational, and invasive capabilities. Transduction of the mutation Y925F resulted in a down-regulation of the phosphorylation of Erk, the expression of VEGF, and the association of FAK with paxillin. The results provide clear evidence that 925Y of FAK is critical for melanoma metastasis and this phosphorylation site will be an anti-metastatic target.

KW - B16F10 cells

KW - Erk

KW - FAK

KW - Metastasis

KW - Paxillin

KW - Y925F-mutation

UR - http://www.scopus.com/inward/record.url?scp=52149083736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52149083736&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2008.05.042

DO - 10.1016/j.canlet.2008.05.042

M3 - Article

C2 - 18606490

AN - SCOPUS:52149083736

VL - 270

SP - 354

EP - 361

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -